Results 111 to 120 of about 53,295 (182)

Red Cells Bound to Influenza Virus N9 Neuraminidase Are Not Released by the N9 Neuraminidase Activity

, 1995
Influenza virus neuraminidase (NA) of the N9 subtype also possesses hemagglutinin activity and the hemagglutinating, or hemabsorbing (HB), site is distinct from the catalytic site.
Air, Gillian M., Laver, W.Graeme
core   +1 more source

Molecular dynamics and free energy analysis of neuraminidase-ligand interactions

, 2004
We report molecular dynamics calculations of neuraminidase in complex with an inhibitor, 4-amino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid (N-DANA), with subsequent free energy analysis of binding by using a combined molecular mechanics/continuum ...
Bonnet, Pascal, Bryce, Richard A.; id_orcid, Pascal Bonnet, Richard A. Bryce   +3 more
core   +1 more source

Illuminating Immunity: Unveiling the Dance of Protective Antibodies Against Influenza Neuraminidase in Seasonal Vaccination

This image illustrates the induction of protective antibodies against influenza neuraminidase (NA) protein by seasonal vaccination (syringe). The dynamic flow of light symbolizes the vaccination procedure.
Wang, Yiquan
core  

Antiviral Susceptibility of Clade 2.3.4.4b H5N1 and H5N5 Influenza Viruses Detected in Birds in Russia During 2021-2022. [PDF]

Viruses
Svyatchenko SV, Goncharova NI, Susloparov IM, Vasiltsova NN, Kolosova NP, Egorova ML, Tregubchak TV, Danilchenko NV, Ilyicheva TN, Marchenko VY.   +9 more
europepmc   +1 more source

Susceptibility of human neural stem cells to SARS-CoV-2: Entry mechanisms and glycocalyx influence. [PDF]

PLoS One
Song A, Zuvia C, Talbot P.
europepmc   +1 more source

Computational antiviral drug design

, 2010
This study designed and computational docked a group of ligands intended to find potent inhibitors for Neuraminidase 4 which would have strong interactions with 8 conserved amino acids in the active site. Several trials of ligands were designed based on
Liu, Lishan
core  

Emergence and spread of NA-I223V and NA-S247N double-mutant A(H1N1)pdm09 influenza viruses with reduced oseltamivir susceptibility in the Netherlands and beyond, 2023 to 2026. [PDF]

Euro Surveill
Felix Garza Z, Eggink D, Bagheri M, van den Brink S, Goderski G, Pronk M, Lexmond P, Hooiveld M, van Gageldonk-Lafeber R, Koel B, Fouchier R, Meijer A.   +11 more
europepmc   +1 more source

Antiviral Activity of the Polyene Macrolide Roseofungin Against Influenza a Virus: In Vitro, In Ovo, and Preliminary In Vivo Evaluation. [PDF]

Viruses
Bogoyavlenskiy A, Berezin V, Alexyuk P, Alexyuk M, Zaitseva I, Mukhametkaliyev A, Moldakhanov Y, Anarkulova E, Kerimov T, Dushenkov V.   +9 more
europepmc   +1 more source

Broadly reactive antibodies against influenza B virus hemagglutinin neutralize and protect through distinct structural mechanisms. [PDF]

J Virol
Bhavsar D, Civljak A, Bonnettaz B, Arunkumar GA, Krammer F, Bajic G.   +5 more
europepmc   +1 more source

Signal mining of adverse reactions for neuraminidase inhibitors in pregnant women: a disproportionality analysis based on the FDA adverse event reporting system database. [PDF]

Front Med (Lausanne)
Cao B, Shen M, Du C, Song Q, Ma Z.
europepmc   +1 more source